Vaxcyte Names Luis Jodar Chief Medical Officer
Vaxcyte appointed Luis Jodar as chief medical officer as its 31-valent pneumococcal conjugate vaccine, VAX-31, approaches Phase III adult readouts and a planned biologics-license application. Jodar previously spent 17 years at Pfizer and most…
